Notably, the ELL(C595A) mutant not only lost its ability to suppress cell proliferation and xenograft tumour growth, but also promoted metastasis, likely by gaining an invasive capability, which is similar to that exhibited by classic tumour suppressors, such as p53 and pVHL61, 62. The gene discussed is TP53; the disease is neoplasm.